{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:55:38Z","timestamp":1792608938019,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1053\/j.seminhematol.2016.04.021","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T20:06:12Z","timestamp":1460232372000},"page":"S70-S72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S1","title":["Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia"],"prefix":"10.1053","volume":"53","author":[{"given":"Mohsen S.","family":"Elalfy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2016.04.021_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","article-title":"Platelets and viruses: an ambivalent relationship","volume":"67","author":"Flaujac","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.seminhematol.2016.04.021_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection\u2014an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.04.021_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1179\/1607845413Y.0000000084","article-title":"The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia","volume":"18","author":"Wu","year":"2013","journal-title":"Hematology"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.04.021_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09537109509078447","article-title":"Platelet membrane glycoprotein IIb\/IIIa has sequence homologies with human virus proteins and synthetic viral peptides inhibit anti-GPIIb\/IIIa antibodies in autoimmune thrombocytopenic purpura","volume":"6","author":"Boughton","year":"1995","journal-title":"Platelets"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.04.021_bib5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s12032-009-9305-x","article-title":"Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B","volume":"27","author":"Allegra","year":"2010","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminhematol.2016.04.021_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/5584_2015_162","article-title":"The influence of primary cytomegalovirus or Epstein-Barr virus infection on the course of\u00a0idiopathic thrombocytopenic purpura","volume":"878","author":"Smalisz-Skrzypczyk","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.04.021_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2141.2009.07714.x","article-title":"Cytomegalovirus can make immune\u00a0thrombocytopenic\u00a0purpura\u00a0refractory","volume":"146","author":"DiMaggio","year":"2009","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2016.04.021_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1651-2227.2010.01842.x","article-title":"Post varicella\u00a0 thrombocytopenic\u00a0purpura","volume":"99","author":"Amir","year":"2010","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.04.021_bib9","first-page":"484","article-title":"The inhibition effect of anti-GPIIIa49\u201366 antibody on megakaryocyte differentiation","volume":"106","author":"Pan","year":"2011","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.04.021_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12098-012-0755-3","article-title":"Immune thrombocytopenic purpura\u00a0due to mixed viral infections","volume":"80","author":"Kumar","year":"2013","journal-title":"Indian J Pediatr"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.04.021_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/QAD.0000000000000947","article-title":"HIV\/AIDS in South Africa: how many people died from the disease between 1997 and 2010?","volume":"30","author":"Bradshaw","year":"2016","journal-title":"AIDS"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.04.021_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00917568","article-title":"Transient disappearance of immunologic disorders and remission after recurrent measles infectionsin children with chronic idiopathic thrombocytopenic purpura","volume":"8","author":"Lin","year":"1988","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.04.021_bib13","first-page":"15","article-title":"Immune thrombocytopenia as a complication of acute infectious diseases\u2014case reports","volume":"19","author":"Sm\u00ed\u0161kov\u00e1","year":"2013","journal-title":"Klin Mikro biol Infekc Lek"},{"issue":"2-4","key":"10.1053\/j.seminhematol.2016.04.021_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000321379","article-title":"An experience oseltamivir phosphate Tamiflu in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report","volume":"37","author":"Alioglu","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"20","key":"10.1053\/j.seminhematol.2016.04.021_bib15","article-title":"Severe immune thrombocytopenia possibly elicited by the anti-influenza\u00a0viral agent peramivir","volume":"53","author":"1Harada-Shirado","year":"2014","journal-title":"Intern Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2016.04.021_bib16","first-page":"1","article-title":"Patients","volume":"6","author":"Farag","year":"2015","journal-title":"Virology (Auckl)"},{"key":"10.1053\/j.seminhematol.2016.04.021_bib17","first-page":"381","article-title":"Thrombocytopenia in chronic hepatitis C","volume":"19","author":"Olariu","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"issue":"11","key":"10.1053\/j.seminhematol.2016.04.021_bib18","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1128\/AAC.03091-14","article-title":"Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir","volume":"58","author":"Wire","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.04.021_bib19","article-title":"Romiplostim for severe thrombocytopenia in the treatment of chronic hepatitis C virus infection: a new option for clinicians?","volume":"37","author":"Buccoliero","year":"2014","journal-title":"New Microbiol"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.04.021_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0961203313499959","article-title":"Immune thrombocytopaenic\u00a0purpura: an autoimmune cross-link between infections and vaccines","volume":"23","author":"Rinaldi","year":"2014","journal-title":"Lupus"},{"issue":"49","key":"10.1053\/j.seminhematol.2016.04.021_bib21","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunization with influenza A \/H1N1 vaccines with and without adjuvant: Eudra Vigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"issue":"2-3","key":"10.1053\/j.seminhematol.2016.04.021_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.04.021_bib23","article-title":"The risk of immune\u00a0thrombocytopenic\u00a0purpura\u00a0after vaccination in children and adolescents","volume":"129","author":"O\u2019Leary","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"10.1053\/j.seminhematol.2016.04.021_bib24","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2006.10.054","article-title":"Vaccination associated thrombocytopenic purpura in children. NOPHO ITP working group and five national study groups","volume":"25","author":"Rajantie","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.04.021_bib25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children","volume":"9","author":"Cecinati","year":"2013","journal-title":"Hum Vaccin Immunother"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:25:04Z","timestamp":1758522304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196316300336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":25,"alternative-id":["S0037196316300336"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.04.021","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}